Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare Rx Implementing Regs Open For Comment

Executive Summary

CMS' schedule for the Medicare prescription drug benefit implementing regulations will give the agency 15 weeks to review comments and finalize the rule before Inauguration Day

You may also be interested in...



Medicare Rx Regs Will Be Final By February, CMS Says

The Medicare Part D regulations will need to be made final by February to give prescription drug plan sponsors adequate time to make bids for participation, Centers for Medicare & Medicaid Services Division of Plan Policy Director Thomas Hutchinson said

Medicare Rx Regs Will Be Final By February, CMS Says

The Medicare Part D regulations will need to be made final by February to give prescription drug plan sponsors adequate time to make bids for participation, Centers for Medicare & Medicaid Services Division of Plan Policy Director Thomas Hutchinson said

CMS Considering Obesity Drug Coverage Under Medicare Rx Benefit

The Centers for Medicare & Medicaid Services is seeking comment on how obesity treatments can be covered under the Medicare Rx benefit despite language in the law that prohibits coverage of "weight loss" drugs

Related Content

Topics

Latest News
UsernamePublicRestriction

Register

PS044433

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel